Videos | Bringing pharma’s top innovators to your screen

Skip to main content

Friday 5 December 2025

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Market Access

Consolidating data strategy for global success: Insights from Frontiers Health 2025

Consolidating data strategy for global success: Insights fro...

At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.

Sales & Marketing

HCP and patient looking positive

Sponsored

Bridging science and strategy: Medical Affairs at the heart ...

In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.

Digital

Consolidating Digital Health: Insights from Frontiers Health 2025

Consolidating Digital Health: Insights from Frontiers Health...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.

Digital

Building a Molecular Time Machine: Insights from Frontiers Health 2025

Building a Molecular Time Machine: Insights from Frontiers H...

pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.

Digital

Humans in Extremes: Insights from Frontiers Health 2025

Humans in Extremes: Insights from Frontiers Health 2025

pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.

Oncology

Interview at ASCO 2025 with Dr Gregory Lubiniecki

Merck and oncology: A conversation with Dr Gregory Lubinieck...

R&D

Interview at BIO 2025 with Juergen Eckhardt

Looking to early-stage companies for innovation, with Juerge...

In an interview at BIO 2025, Bayer's Juergen Eckhardt discusses the importance of external innovation and why his company is prioritising early stage.

R&D

Interview at BIO 2025 with Jeffrey Meckler

Going wide on immune system activation, with Jeffrey Meckler

Indaptus CEO Jeff Meckler discusses his company's unconventional approach to immunotherapy, based on activating a wide swath of the immune system.

Load more results

Sales & Marketing

Sales & Marketing

HCP and patient looking positive

Sponsored

Bridging science and strategy: Medical Affairs at the heart ...

In this sponsored podcast, Cheryl Lubbert and Carolyn Whiting of Reverba discuss a new approach to pharma marketing, omnichannel, and medical affairs.

Sales & Marketing

The Future of Pharma Marketing featuring Dan Gandor, Brooke Fleming, Stacy Stone, Tarak Shah and Paul Murasko

The future of pharma marketing – A pharmaphorum executive ro...

Digital

Digital

Consolidating Digital Health: Insights from Frontiers Health 2025

Consolidating Digital Health: Insights from Frontiers Health...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights.

Digital

Building a Molecular Time Machine: Insights from Frontiers Health 2025

Building a Molecular Time Machine: Insights from Frontiers H...

pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.

Market Access

Market Access

Consolidating data strategy for global success: Insights from Frontiers Health 2025

Consolidating data strategy for global success: Insights fro...

At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.

Market Access

Interview at BIO 2025 with Paul Romness and Farah Ahmad

Global unity in the face of uncertainty, with Paul Romness a...

Editor's Picks

UK and US agree zero tariffs on pharma – with price rises

FDA clears trial of 'vectorised' ALS antibody from VectorY

Tracy Beth Hoeg will be fifth CDER head this year

FDA takes steps to limit non-human primate testing

FDA could hike user fees for ex-US drug programmes

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Interview at ESMO 2025 with Dr Ebrahim Delpassand

ESMO25: On radiopharmaceutical possibilities in oncology, wi...

At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix.

Oncology

Interview at ESMO 2025 with Michael Lahn, iOnctura

ESMO25: On allosteric modulation in oncology, with Michael L...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura.

Oncology

Interview at ESMO 2025 with Sandeep Reddy, Immunity Bio

ESMO25: Harnessing the innate and the adaptive immune respon...

As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.

Patients

Patients

Where Patients Lead: Insights from Frontiers Health 2025

Where Patients Lead: Insights from Frontiers Health 2025

At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story.

Patients

Jonah Comstock at AAPS interviewing Mehul Desai

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

Patients

Reuters pharma USA 2025 Faruk Abdullah interview

Direct-to-patient is more than just telehealth – with EVERSA...

Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.

R&D

R&D

Interview at ESMO 2025 with Jane Li

ESMO25: On partnerships between pharma and diagnostic develo...

Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.

R&D

Interview at LSX 25 with Teresa Whalen

Bolstering CAR-T therapies by tackling CRS, with Teresa Whal...

In interview with Teresa Whalen, the CEO of CytoAgents, a clinical-stage drug development company working on a treatment for cytokine release syndrome

R&D

Interview at LSX 25 with Steffen Sebastian Bolz

A different approach to obesity treatment, with Steffen-Seba...

At LSX 2025, editor-in-chief Jonah Comstock connected with Dr Steffen Sebastian-Bolz, chief science officer at Aphaia Pharma.

Editor's Picks

UK and US agree zero tariffs on pharma – with price rises

FDA clears trial of 'vectorised' ALS antibody from VectorY

Tracy Beth Hoeg will be fifth CDER head this year

FDA takes steps to limit non-human primate testing

FDA could hike user fees for ex-US drug programmes

News

CDC panel votes to scrap hepatitis B birth dose advice

CDC panel votes to scrap hepatitis B birth dose advice

CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company